Former FDA commissioner joins J&J board
This article was originally published in Scrip
Executive Summary
Johnson and Johnson has appointed Dr Mark B McClellan to its board of directors – effective 15 October 2013. He will serve on the regulatory, compliance and government affairs committee, and the science, technology and sustainability committee. Prior to joining the New Brunswick, New Jersey-headquartered firm, Dr McClellan was commissioner of the US FDA from 2002-2004 and administrator the Centers for Medicare and Medicaid services, a department of US Health and Human Services, from 2004-2006. Currently, Dr McClellan is senior fellow in economic studies, and director of the initiative on value and innovation in healthcare at Brookings Institution.